DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Prosthetic joint infections - Pipeline Review, H2 2016" report to their offering.
Prosthetic joint infection (PJI) is one of the most serious complications of prosthetic joint implantation. Symptoms include pain or stiffness in joints, swelling, redness around the wound, fatigue and fever. Risk factors include age, prior arthroplasty, poor nutritional status, obesity, diabetes mellitus and advanced HIV disease. Treatment includes antimicrobial therapy.
This report provides comprehensive information on the therapeutic development for Prosthetic joint infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Prosthetic joint infections and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Companies Mentioned
- Cempra Inc
- Motif Bio Plc
- Nabriva Therapeutics AG
- Telephus Medical LLC
Key Topics Covered:
- Introduction
- Prosthetic joint infections Overview
- Therapeutics Development
- Pipeline Products for Prosthetic joint infections - Overview
- Pipeline Products for Prosthetic joint infections - Comparative Analysis
- Prosthetic joint infections - Therapeutics under Development by Companies
- Prosthetic joint infections - Therapeutics under Investigation by Universities/Institutes
- Prosthetic joint infections - Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Prosthetic joint infections - Products under Development by Companies
- Prosthetic joint infections - Products under Investigation by Universities/Institutes
- Prosthetic joint infections - Companies Involved in Therapeutics Development
For more information about this report visit http://www.researchandmarkets.com/research/x9ccj3/prosthetic_joint
